top of page

Our team

P1060266_cropped_edited.jpg

Emin Ekström

MSc
Senior Analyst,
Health economics

Emin has over 10 years of experience from health technology assessment and RWD studies resulting in a broad set of skills in various areas such as economic evaluations, economic modelling, reimbursement submissions, registry-based studies, literature reviews, and a deep understanding of the health care system.

Prior to joining Macanda, Emin worked as a Health economist at The Dental and Pharmaceutical Benefits Agency (TLV) , Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU), The Ministry of Health and Social affairs and as a commissioned researcher for the region of Västra Götaland performing large data merges and analysis.

Emin has had the responsibility to assess and evaluate reimbursement submissions in many theraputical areas including orphan drugs, and also be a part of the development of FINOSE and the ongoing government assignment regarding ATMP at TLV. He has a long background in working with evidence synthesis, systematic literature reviews and transferability of economic evaluations to a Swedish setting. Emin has also had the responsibility to evaluate the cost consequences of implementing new laws to prepare the health care for the next crisis and have full responsability of large collaborating RWD projects with the pharmaceutical industry, academia and the region of Västra Götaland.Emin has had the responsibility to assess and evaluate reimbursement submissions in many theraputical areas including orphan drugs, and also be a part of the development of FINOSE and the ongoing government assignment regarding ATMP at TLV. He has a long background in working with evidence synthesis, systematic literature reviews and transferability of economic evaluations to a Swedish setting. Emin has also had the responsibility to evaluate the cost consequences of implementing new laws to prepare the health care for the next crisis and have full responsability of large collaborating RWD projects with the pharmaceutical industry, academia and the region of Västra Götaland.

Emin holds a MSc in Health economics and Public health, Sahlgrenska Academy at The University of Gothenburg.

EM_edited_edited.jpg

Emma Medin

MD, MSc
CEO, Partner, Senior Advisor
Market Access & HTA
ÅB_edited_edited.jpg

Åsa By

MSc
Chairman of the board,
Partner, Senior Advisor
Market Access & Launch
ES_edited_edited.jpg

Emma Söreskog

MSc, PhDc
Partner, Senior Advisor Health Economics & Analytics
P1060240_crop2_edited.jpg

Josefine Röhss

MSc
Senior Consultant Health Economics & Statistics
MH_edited.jpg

Marcus Hultberg

MSc
Partner, Senior Advisor Strategy & HTA
JL_edited.jpg

Jonas Lindblom

PhD, MSc
Partner, Senior Advisor Clinical Value & HTA
P1060257C2_edited.jpg

Chantelle Murley

PhD, MSc
Analyst,
Market Access & HTA
P1060266_cropped_edited.jpg

Emin Ekström

MSc
Senior Analyst, Health economics

Maria Johansson

MSc
Director,
Clinical Value & HTA

August Wadell Leimdörfer

MSc
Analyst,
Health Economics
DSC_4296_cropped.jpg

Klas Kellerborg

PhD, MSc
Consultant,
Health Economics & RWE
DSC_4288_cropped.jpg

Angelina Schwarz

PhD, MSc
Intern
DSC_4433.jpg

Tobias Lindström Battle

MSc
Analyst,
Market Access & HTA
DSC_4419.jpg

Anna Oksanen

MSc
Senior Analyst
Statistics & Health Economics
DSC_4536 (1)_edited_edited.jpg

Johannes Lissdaniels

MSc
Consultant
Health Economics & Statistics
bottom of page